Twin Tree Management
HAE icon

Twin Tree Management’s Haemonetics HAE Stock Holding History

Twin Tree Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-244
Closed -$22K – 1373
2020
Q2 		$22K Sell
244
-4,603
-95% -$465K ﹤0.01% 1376
2020
Q1 		$483K Buy
+4,847
New +$526K ﹤0.01% 976
2019
Q2 		– Sell
-96
Closed -$8K – 1367
2019
Q1 		$8K Buy
+96
New +$8.73K ﹤0.01% 1185

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Twin Tree Management's HAE Position: Q3 2020 in Review

Twin Tree Management sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 244 shares — an estimated $22K sold.

Twin Tree Management first reported a position in HAE in Q1 2019 and held it in 3 quarters. The position peaked at $483K in Q1 2020. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • Twin Tree Management reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
  • Twin Tree Management sold 244 Haemonetics shares in Q3 2020, an estimated $22K.
  • Twin Tree Management first reported a position in Haemonetics in Q1 2019 and held it in 3 quarters.
  • Twin Tree Management's Haemonetics position peaked at $483K in Q1 2020.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Twin Tree Management's 13F filing for Q3 2020, filed 13 Nov 2020.